BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 467489)

  • 1. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML; Domzig W; Taskov H
    Eur J Immunol; 1979 Apr; 9(4):261-6. PubMed ID: 467489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity against tumor cells. II. The promonocyte identified as effector cell.
    Domzig W; Lohmann-Matthes ML
    Eur J Immunol; 1979 Apr; 9(4):267-72. PubMed ID: 467490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promonocytes have the functional characteristics of natural killer cells.
    Lohmann-Matthes ML; Domzig W; Roder J
    J Immunol; 1979 Oct; 123(4):1883-6. PubMed ID: 479604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1985 Apr; 134(4):2658-65. PubMed ID: 3882833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).
    Meerpohl HG; Lohmann-Matthes ML; Fischer H
    Eur J Immunol; 1976 Mar; 6(3):213-7. PubMed ID: 1086777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.
    Kohl S; Cahall DL; Walters DL; Schaffner VE
    J Immunol; 1979 Jul; 123(1):25-30. PubMed ID: 448149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of long-term cultures of proliferating, mononuclear phagocytes from bone marrow.
    van der Meer JW; van de Gevel JS; van Furth R
    J Reticuloendothel Soc; 1983 Sep; 34(3):203-25. PubMed ID: 6620253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
    Koren HS; Hodes RJ
    Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
    Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADCC mediated by non-adherent mononuclear and polymorphonuclear cells of the guinea-pig.
    Hopkins SJ; Dale MM
    Immunology; 1980 Aug; 40(4):513-9. PubMed ID: 7429541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous cytotoxic T cells in murine spleen-cell cultures. I. Some characteristics of effector and precursor cells.
    Ezaki T; Skinner MA; Marbrook J
    Immunology; 1983 Nov; 50(3):343-9. PubMed ID: 6605301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-GuĂ©rin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A; Riccardi C; Sorci V; Herberman RB
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.